Regenerex Pharma auditor dbbmckennon exits engagement, company seeks successor firm

• Regenerex Pharma’s auditor dbbmckennon resigned effective Aug. 31, 2026, citing an internal decision to stop serving the company.
• Audit reports for fiscal years ended Dec. 31, 2025 and March 31, 2025 carried going-concern warnings.
• A transition-period report also flagged a revision to disclose certain related-party transactions.
• No reported accounting or audit-scope disputes with dbbmckennon over the two most recent fiscal years.
• Company is seeking a successor auditor while working to bring outstanding periodic filings current.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenerex Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001472375-26-000217), on September 04, 2026, and is solely responsible for the information contained therein.